% Expired Patents = 71.4

CIPO Patents = 1

EPO Patents = 5

Trademarks = 1

Forward Citations = 51

Loading Chart...

9 inventors (with patents filed for the assignee):

Julien Mamet (7 out of 9 patents)

Rick Orr (2 out of 4 patents)

Scott Harris (2 out of 6 patents)

4. William Martin (1 out of 2 patents)

5. George Miljanich (1 out of 2 patents)

6. William K Schmidt (1 out of 2 patents)

7. Tony Yaksh (1 out of 2 patents)

8. David C Yeomans (1 out of 2 patents)

9. Don Manning (1 out of 1 patent)

7 patents: Sort by Forward Citations

1. 10287583 - Oligonucleotide decoys for the treatment of pain (2019-05-14),

2. 10041069 - Gene expression and pain (2018-08-07),

3. 9700624 - Formulations for the delivery of active ingredients (2017-07-11),

4. 9290762 - Gene expression and pain (2016-03-22),

5. 8741864 - Gene expression and pain (2014-06-03),

6. 8093225 - Gene expression and pain (2012-01-10),

7. 7943591 - Gene expression and pain (2011-05-17),

Company Overview

Adynxx is a clinical-stage biopharmaceutical company focused on developing transformative therapies for pain and inflammatory diseases. Using its proprietary technology platform, Adynxx aims to address the limitations of existing pain treatments and improve patient outcomes. The company's lead product candidate, AYX1, is being developed for the prevention of postoperative pain and has the potential to revolutionize pain management.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

7 Patents

#598 in San Francisco, CA

#9,508 in California

#39,929 in US

San Francisco, CA, United States of America

Adynxx, Inc.

Forward Citations = 51

9 inventors:

Julien Mamet (7 out of 9 patents)

Rick Orr (2 out of 4 patents)

Scott Harris (2 out of 6 patents)

4. William Martin (1 out of 2 patents)

5. George Miljanich (1 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Adynxx, Inc.. Retrieved from https://idiyas.com/company/adynxx

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

5 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]